Structural Studies of Coronavirus Fusion Proteins
冠状病毒融合蛋白的结构研究
基本信息
- 批准号:9324294
- 负责人:
- 金额:$ 29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesAntigensArchitectureAttentionBindingBiological AssayBiological ModelsCell fusionCell membraneCell-Matrix JunctionCellsChimeric ProteinsComplementComplexCoronaviridaeCoronavirusCoronavirus InfectionsCoronavirus spike proteinCryoelectron MicroscopyDataData AnalysesDisease OutbreaksFamilyFosteringFutureGenetic MaterialsGenomeGlycoproteinsGoalsHealthHumanImmunizationImmunoglobulin FragmentsInfectionKineticsLeadMediatingMembraneMembrane FusionMiddle East Respiratory Syndrome CoronavirusModelingMolecularMolecular ConformationMurine hepatitis virusMusMutagenesisN-terminalNegative StainingOutcomePathogenicityPneumoniaProcessProtein EngineeringProteinsReactionResolutionStructureSurfaceThermodynamicsViralViral Fusion ProteinsVirusVirus DiseasesWorkantibody engineeringantibody inhibitorbiophysical techniquescoronavirus spike glycoproteindesignexperimental studygraspmutantneutralizing antibodypandemic diseaseparticlepreventreceptorreceptor bindingreconstructionsmall molecule inhibitorstemtargeted treatmenttherapeutic targetthree-dimensional modelingvaccinologyvirus envelope
项目摘要
Enveloped viruses use specialized proteins present at the virus surface to translocate their genetic
material across the host cell membrane during infection. For coronaviruses, homotrimers of the spike
glycoprotein promote host cell attachment and fusion of the viral and host membranes. Although
coronaviruses have a significant pandemic potential, the lack of high-resolution data for any
coronavirus spike trimer limits our mechanistic understanding of infection by this family of viruses.
The objective of the proposed work is to obtain high-resolution snapshots corresponding to the
various stages of the fusion reaction mediated by coronavirus spikes and to study the structural
determinants associated with antibody inhibition of viral infection. In Aim I, we propose to elucidate
the architecture of the Mouse Hepatitis Virus (MHV) pre-fusion spike using cryoEM. Aim II will be
dedicated to studying the conformational changes associated with the fusion reaction with an
emphasis on the first intermediate (extended intermediate) and the post-fusion spike. In Aim III, we
will characterize the 3D organization of human coronavirus spikes to understand how these viruses
overcome the species barrier and to identify structurally conserved regions that could be potential
targets for therapeutic initiatives. The final aim will rely on structure-guided protein design to engineer
antibodies targeting human coronavirus spikes with the goal of identifying immunogens for raising
broadly-neutralizing antibodies.
有包膜病毒利用病毒表面的特殊蛋白质来转移它们的基因,
在感染期间穿过宿主细胞膜的物质。对于冠状病毒,刺突的同三聚体
糖蛋白促进宿主细胞附着以及病毒和宿主膜的融合。虽然
冠状病毒具有重大的大流行潜力,缺乏任何高分辨率数据,
冠状病毒刺突三聚体限制了我们对该病毒家族感染的机制理解。
所提出的工作的目标是获得高分辨率快照对应的
冠状病毒刺突介导的融合反应的各个阶段,并研究其结构
与抗体抑制病毒感染相关的决定因素。在目的I中,我们建议澄清
使用cryoEM的小鼠肝炎病毒(MHV)融合前刺突的结构。目标二是
致力于研究与融合反应相关的构象变化,
强调第一中间体(延伸中间体)和融合后尖峰。在Aim III中,我们
将描述人类冠状病毒尖峰的3D组织,以了解这些病毒如何
克服物种障碍,并确定结构保守的区域,
治疗计划的目标。最终的目标将依赖于结构导向的蛋白质设计,
针对人类冠状病毒刺突的抗体,目的是鉴定用于提高
广泛中和抗体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Veesler其他文献
David Veesler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Veesler', 18)}}的其他基金
Project 1: Definition of the structural principles underlying broadly protective humoral immunity to coronaviruses
项目 1:冠状病毒广泛保护性体液免疫的结构原理的定义
- 批准号:
10425030 - 财政年份:2022
- 资助金额:
$ 29万 - 项目类别:
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics
揭示蝙蝠针对人畜共患病毒的体液免疫反应,以指导下一代疗法的设计
- 批准号:
10670195 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics
揭示蝙蝠针对人畜共患病毒的体液免疫反应,以指导下一代疗法的设计
- 批准号:
10462736 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics
揭示蝙蝠针对人畜共患病毒的体液免疫反应,以指导下一代疗法的设计
- 批准号:
10240475 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 29万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 29万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 29万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 29万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 29万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 29万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 29万 - 项目类别:
Standard Grant